We are live on ! Find out more
ORKA

Oruka Therapeutics
ORKA

14 hedge funds and large institutions have $756K invested in Oruka Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

17% more funds holding

Funds holding: 12 → 14 (+2)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

6% less capital invested

Capital invested by funds: $805K → $756K (-$49.2K)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$109K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$24.6K
3
OC
Oppenheimer & Co
New York
+$23.4K
4
HighTower Advisors
HighTower Advisors
Illinois
+$8.19K
5
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$2.34K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$81K
2
VKH
Virtu KCG Holdings
New York
-$17.6K
3
UBS Group
UBS Group
Switzerland
-$11.7K
4
Citigroup
Citigroup
New York
-$1K

ORKA Hedge Fund Activity: Q1 2015 in Review

14 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q1 2015, worth a combined $756K — down 6.1% from $805K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ORKA positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $109K. The largest seller was Anson Funds Management, exiting entirely with an estimated $81K sold.

  • 14 institutional investors held Oruka Therapeutics (ORKA) as of Q1 2015, up from 12 in Q4 2014.
  • Funds reported $756K of Oruka Therapeutics stock for Q1 2015, down 6.1% quarter-over-quarter.
  • 4 funds opened new Oruka Therapeutics positions in Q1 2015 and 2 closed out, a net change of +2 holders.
  • The largest Oruka Therapeutics buyer in Q1 2015 was Sabby Management, an estimated $109K added.
  • The largest Oruka Therapeutics seller in Q1 2015 was Anson Funds Management, an estimated $81K sold.

Based on aggregated 13F filings for Q1 2015.